I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Surface engineered mesoporous silica carriers for the contr..:
Fozia Rehman
;
Asif Jamal Khan
;
Zaib Us Sama
...
https://www.frontiersin.org/articles/10.3389/fphar.2023.1146562/full. , 2023
Link:
https://doi.org/10.3389/fphar.2023.1146562
RT Journal T1
Surface engineered mesoporous silica carriers for the controlled delivery of anticancer drug 5-fluorouracil: Computational approach for the drug-carrier interactions using density functional theory
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:3c436a7181e148d2863bad4c55a817d7&Exemplar=1&LAN=DE A1 Fozia Rehman A1 Asif Jamal Khan A1 Zaib Us Sama A1 Hussah M. Alobaid A1 Mazhar Amjad Gilani A1 Sher Zaman Safi A1 Nawshad Muhammad A1 Abdur Rahim A1 Abid Ali A1 Jiahua Guo A1 Muhammad Arshad A1 Talha Bin Emran PB Frontiers Media S.A. YR 2023 K1 surface modification K1 SBA-15 K1 5-fluorouracil K1 drug–carrier interactions K1 anti-cancer K1 DFT K1 Therapeutics. Pharmacology K1 RM1-950 JF https://www.frontiersin.org/articles/10.3389/fphar.2023.1146562/full LK http://dx.doi.org/https://doi.org/10.3389/fphar.2023.1146562 DO https://doi.org/10.3389/fphar.2023.1146562 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)